TGFB1 and non-small cell lung carcinoma: Both canonical (Smad-dependent) and non-canonical (e.g., MAPK/PI3K) TGF-β pathways remodel the ECM, promote angiogenesis, and facilitate metastatic dissemination, with elevated TGF-β levels correlating with poor prognosis in NSCLC cohorts [56].